Protagenic Therapeutics, Inc. (PTIX)
0.59
+0.05
(+9.26%)
USD |
OTCM |
Jan 16, 16:00
Protagenic Therapeutics Total Liabilities (Quarterly): 9.703M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 11.00B |
| Vanda Pharmaceuticals, Inc. | 135.14M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
| Theriva Biologics, Inc. | 24.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.003M |
| Shareholders Equity (Quarterly) | -4.701M |
| Debt to Equity Ratio | -0.8504 |
| Current Ratio | 0.2946 |
| Net Debt Paydown Yield | -39.57% |